Table of Contents  by unknown
CH
D
CDVol. 144, No. 3, September 2012
Table of ContentsAPresidential
Perspectives
527 Historical perspectives of The American Association for Thoracic Surgery:
Edward M. Kent (1908-1970)(continued on page 14A
The Journal of Thoracic and Cardiovascular Surgery c Volume 144, Number 3 13AChristopher E. Mascio, MD, and J. William Gaynor, MD, Louisville, Ky,
and Philadelphia, PaPoint/Counterpoint 530 An issue of accountabilityPMCary W. Akins, MD, Boston, Mass532 Who will determine the educational needs of our trainees?
Ara Asadur Vaporciyan, MD, Houston, TexClinical Guidelines 534 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter
aortic valve replacement: Executive summarySArvind Agnihotri, MD, Beverly, Mass/Be29 2012 ACCF/AATS/SCAI/STS expert consensus document on
transcatheter aortic valve replacement: Developed in collabration
with the American Heart Association, American Society of
Echocardiography, European Association for Cardio-Thoracic
Surgery, Heart Failure Society of America, Mended Hearts, Society
of Cardiovascular Anesthesiologists, Society of Cardiovascular
Computed Tomography, and Society for Cardiovascular Magnetic
ResonanceET
TXDavid R. Holmes, Jr, MD, FACC, Michael J. Mack, MD, FACC, Sanjay Kaul, MBBS, FACC,
Arvind Agnihotri, MD, Karen P. Alexander, MD, FACC, Steven R. Bailey, MD, FACC, FSCAI,
John H. Calhoon, MD, Blase A. Carabello, MD, FACC, Milind Y. Desai, MBBS, FACC,
Fred H. Edwards, MD, FACC, Gary S. Francis, MD, FACC, Timothy J. Gardner, MD, FACC,
A. Pieter Kappetein, MD, PhD, Jane A. Linderbaum, MS, CNP, AACC,
Chirojit Mukherjee, MD, Debabrata Mukherjee, MD, FACC, Catherine M. Otto, MD, FACC,
Carlos E. Ruiz, MD, PhD, FACC, FSCAI, Ralph L. Sacco, MD, MS, FAHA,
Donnette Smith, and James D. Thomas, MD, FACC)
Table of Contents (continued)CH
D
A
CD
PM
ET/B
S
TXExpert Review 514A The Journal of Thoracic an38 Implications and management of anemia in cardiac surgery: Current state of
knowledge(continued on page 16A
d Cardiovascular Surgery c September 2012Gabriel Loor, MD, Colleen G. Koch, MD, MS, MBA, Joseph F. Sabik III, MD, Liang Li, PhD, and
Eugene H. Blackstone, MD, Cleveland, OhioInterventions that prevent or correct anemia, such as pharmacologic agents or red blood cell
transfusion, are associated with increased postoperative morbidity and mortality. We review the
counterbalancing adverse outcomes associated with tolerating perioperative anemia to begin to
understand the balance of risks between treating and not treating anemia.Congenital Heart
Disease (CHD)
547 Fast-track extubation after modified Fontan procedure
Masato Mutsuga, MD, PhD, Luis G. Qui~nonez, MD, Andrew S. Mackie, MD, SM,
Colleen M. Norris, RN, PhD, B. Elaine Marchak, MD, Jennifer M. Rutledge, MD,
Ivan M. Rebeyka, MD, and David B. Ross, MD, Edmonton, Alberta, CanadaFast-track extubation in the operating room after a modified Fontan operation is feasible. It is
associated with lower CVP, lower positive fluid balance, and decreased need for inotropes in the
intensive care unit. Extubation in the operating room is associated with earlier chest tube removal
and shorter ICU and hospital length of stays.553 Amethod of transcutaneously adjustable pulmonary artery banding for staged
left ventricular retraining
Daniel J. DiBardino, MD, Kellianne Kleeman, BS, and Edward L. Bove, MD, Ann Arbor, MichA method for the placement of a transcutaneously adjustable pulmonary artery band that allows
subsequent adjustments to be made without the need to reenter the chest is described. Adjustments
were successfully performed in all patients requiring band revision. This method facilitates
a gradual increase in ventricular afterload that can be performed as a minor procedure.557 Predictors for use of temporary epicardial pacing wires after pediatric cardiac
surgery
Punkaj Gupta, MBBS, Patricia Jines, MD, Jeffrey M. Gossett, MS, Mit Maurille, NCET,
Frank L. Hanley, MD, V. Mohan Reddy, MD, Christina Y. Miyake, MD, and
Stephen J. Roth, MD, MPH, Little Rock, Ark, and Stanford, CalifThe objective of this study was to determine the predictive factors for the need of pacing wires after
pediatric cardiac surgery. Need for cardioversion in the operating room, presence of 2 or more
intracardiac catheters, severely reduced ventricular ejection fraction, and high serum lactate level
were independent predictors for the use of pacing wires in the early postoperative period.563 Experimental and numeric investigation of Impella pumps as cavopulmonary
assistance for a failing Fontan
Christopher M. Haggerty, BS, Francis Fynn-Thompson, MD, Doff B. McElhinney, MD,
Anne Marie Valente, MD, Neelakantan Saikrishnan, PhD, Pedro J. del Nido, MD, and
Ajit P. Yoganathan, PhD, Atlanta, Ga, and Boston, MassWe investigated the potential to use 3 existing microaxial Impella pumps as cavopulmonary
assistance for a failing Fontan. The right ventricular RP device showed potential to decrease central
venous pressure because of the ability to direct flow into the branch pulmonary artery.)
Table of Contents (continued)CH
D
A
CD
PM
ET/B
S
TX516A The Journal of Thoracic an70 Improving and standardizing capture of pediatric cardiac surgical
complications(continued on page 17A
d Cardiovascular Surgery c September 2012Ganesh Shanmugam, MS, MCh, FRCS, FRCSC, Lauren L. Clark, BSc, Hayley J. Burton, RNFA,
Andrew E. Warren, MD, MSc, FRCPC, Stacy B. O’Blenes, MSc, MD, FRCS(C), and
Camille L. Hancock Friesen, MSc, MD, FRCS(C), FACS, Halifax, Nova Scotia, CanadaThere is no standardized program-wide monitoring of the incidence and severity of
complications in pediatric cardiac surgery. Using standard definitions, 33% of the procedures
(84/292) in a retrospective analysis were associated with 150 complications. A linear
relationship was found between the frequency and severity of complications and surgical
complexity.577 Risk factors for neurodevelopmental impairments in school-age children after
cardiac surgery with full-flow cardiopulmonary bypass
Michael von Rhein, MD, Anastasia Dimitropoulos, MD, Emanuela R. Valsangiacomo Buechel, MD,
Markus A. Landolt, PhD, and Beatrice Latal, MD, MPH, Zurich, Switzerland, and Mainz, GermanyLittle is known of the outcomes and the risk factors for adverse outcomes in children undergoing
full-flow cardiac repair. At school age, the intellectual and neurodevelopmental outcomes are also
poorer in children without a genetic comorbidity. Postoperative complications and
sociodemographic variables play a more important role than the surgical parameters in the
prediction of outcome.Acquired Cardiovascular
Disease (ACD)
584 Long-term mechanical circulatory support (destination therapy): On track to
compete with heart transplantation?
James K. Kirklin, MD, David C. Naftel, PhD, Francis D. Pagani, MD, PhD, Robert L. Kormos, MD,
Lynne Stevenson, MD, Marissa Miller, DVM, MPH, and James B. Young, MD, Birmingham, Ala,
Ann Arbor, Mich, Pittsburgh, Pa, Boston, Mass, Bethesda, Md, and Cleveland, OhioAmong patients subjected to destination therapy continuous flow LVAD in the INTERMACS
Registry who were not in cardiogenic shock, a particularly favorable survival group was
identified with 1- and 2-year survivals of 88% and 80%. Important subsets of continuous flow
DT patients now enjoy survival that is competitive with heart transplantation out to about 2
years.604 Long-term comparison of thoracic endovascular aortic repair (TEVAR) to
open surgery for the treatment of thoracic aortic aneurysms
Nimesh D. Desai, MD, PhD, Kristen Burtch, BS, William Moser, MS, Pat Moeller, BS,
Wilson Y. Szeto, MD, Alberto Pochettino, MD, Edward Y. Woo, MD, Ronald M. Fairman, MD, and
Joseph E. Bavaria, MD, Philadelphia, PaWe compared the long-term outcomes of TEVAR with the 3 commercially available stents
grafts for thoracic aortic aneurysms to control patients undergoing open surgery. TEVAR is
a safe and effective procedure to treat thoracic aortic aneurysms with improved perioperative
and similar long-term results as open thoracic aortic repair. TEVAR-treated aneurysm
diameters initially decrease and then stabilize over time.)
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D612 Nationwide trends and regional/hospital variations in open versus
endovascular repair of thoracoabdominal aortic aneurysms(continued on page 18A
The Journal of Thoracic and Cardiovascular Surgery c Volume 144, Number 3 17AJoshua M. Liao, BS, Faisal G. Bakaeen, MD, Lorraine D. Cornwell, MD, Kiki Simpson, MS,
Scott A. LeMaire, MD, Joseph S. Coselli, MD, and Danny Chu, MD, Houston, TexA
CDWe examined national trends in the use of TEVAR and OTAR to treat thoracoabdominal aortic
aneurysm. During 2005 to 2008, the frequency of OTAR remained stable, whereas the use of
TEVAR increased significantly. Additionally, TEVAR was more common in regions and hospitals
where OTAR was less often performed.617 Influence of operative strategy for the aortic arch in DeBakey type I aortic
dissection: Analysis of the German Registry for Acute Aortic Dissection Type A
Jerry Easo, MD, Ernst Weigang, MD, PhD, Philipp P. F. H€olzl, MD, Michael Horst, MD,
Isabell Hoffmann, MS, Maria Blettner, MS, PhD, and Otto E. Dapunt, MD, PhD, for the GERAADA
study group, Oldenburg and Mainz, GermanyPMPatients treated with an extensive approach including total aortic arch replacement for AADA
may have a favorable long-term prognosis, although they may have a higher perioperative risk.
Analyses of the GERAADA show no significant differences between hemiarch and total arch
replacement in 30-day mortality, onset of new neurologic deficit, or malperfusion deficit.624 Effect of anterior strut chordal transection on the force distribution on the
marginal chordae of the mitral valve
Muralidhar Padala, PhD, Lazarina Gyoneva, BS, and Ajit P. Yoganathan, PhD, Atlanta, GaB
STransection of the secondary chordae on the anterior leaflet of the mitral valve to relieve leaflet
tethering and reduce regurgitation is an experimentally proven procedure to correct functional
mitral regurgitation. In the present study, we sought to investigate whether transecting the
secondary chordae would have an effect on the marginal chordal force on the same leaflet.T/634 Staged percutaneous coronary intervention and minimally invasive valve
surgery: Results of a hybrid approach to concomitant coronary and valvular
diseaseEOrlando Santana, MD, Michael Funk, MD, Carlos Zamora, MD, Esteban Escolar, MD,
Gervasio A. Lamas, MD, and Joseph Lamelas, MD, Miami Beach, FlaA staged approach of percutaneous coronary intervention followed by minimally invasive valve
surgery may be an effective approach for selected patients with suitable coronary and valvular
anatomy when compared with a standard median sternotomy.X
640 Magnetic resonance imaging versus echocardiography to ascertain the
regression of left ventricular hypertrophy after bioprosthetic aortic valve
replacement: Results of the REST studyTIngo Breitenbach, MD, Wolfgang Harringer, MD, Steven Tsui, MD, Mario Jorge Amorim, MD,
Marie-Christine Herregods, MD, PhD, Jan Bogaert, MD, Juan Jose Goiti, MD, and Gino Gerosa,
MD, Braunschweig, Germany, Cambridge, United Kingdom, Porto, Portugal, Leuven, Belgium,
San Sebastian, Spain, and Padua, ItalyWemeasured a significant decrease in LVMI with echocardiography andMRI, 6 months after AVR.
The decrease in LVMI was statistically significant, regardless of valve model or size. Because
echocardiography overestimated its decrease, measurements of LVMI with cardiac MRI are
recommended.)
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618A The Journal of Thoracic an46 Carbon dioxide insufflation in open-chamber cardiac surgery: A double-blind,
randomized clinical trial of neurocognitive effects(continued on page 20A
d Cardiovascular Surgery c September 2012Krish Chaudhuri, MBBS, Elsdon Storey, D Phil, Geraldine A. Lee, MPhil, Michael Bailey, PhD,
Justin Chan, MBBS, Franklin L. Rosenfeldt, MD, Adrian Pick, FRACS, Justin Negri, FRACS, Julian
Gooi, FRACS, Adam Zimmet, FRACS, Donald Esmore, MD, Chris Merry, FRACS, Michael
Rowland, FRACS, Enjarn Lin, FANZCA, and Silvana F. Marasco, MSc, MBBS, FRACS, Melbourne
and Richmond, Victoria, AustraliaDespite widespread use of carbon dioxide insufflation in cardiac surgery, there is scant
evidence to support this. In a randomized, controlled trial examining potential reduction in
postoperative neurocognitive decline. 125 patients were randomly allocated to receive carbon
dioxide or placebo. No differences in neurocognitive functioning were detected 6 weeks
postoperatively.654 Nadir hematocrit during cardiopulmonary bypass: End-organ dysfunction and
mortality
Gabriel Loor, MD, Liang Li, PhD, Joseph F. Sabik III, MD, Jeevanantham Rajeswaran, MSc,
Eugene H. Blackstone, MD, and Colleen G. Koch, MD, MS, MBA, Cleveland, OhioNadir Hct is associated with more end-organ dysfunction and increased resource usage and
mortality. Preoperative anemia is the most significant risk factor for low nadir Hct. The
identification and treatment of preoperative anemia might eliminate the risk associated with both
anemia and red blood cell transfusion.663 Use of modified ultrafiltration in adults undergoing coronary artery bypass
grafting is associated with inflammatory modulation and less postoperative
blood loss: A randomized and controlled study
Anali G. Torina, MS, Lindemberg M. Silveira-Filho, MD, PhD, Karlos A. S. Vilarinho, MD, MS,
Pirooz Eghtesady, MD, PhD, Pedro P. M. Oliveira, MD, PhD, Andrei C. Sposito, MD, PhD, and
Orlando Petrucci, MD, PhD, S~ao Paulo, Brazil, and St Louis, MoModified ultrafiltration is an efficient method for fluid management in the intraoperative period and
can reduce blood loss and the need for blood transfusions in adults after coronary artery bypass
grafting. However, modified ultrafiltration is associated with an increase in some inflammatory
serum markers.671 Early readmission for congestive heart failure predicts late mortality after
cardiac surgery
Richard Lee, MD, MBA, Natalie Homer, BS, Adin-Cristian Andrei, PhD, Edwin C. McGee, MD,
S. Chris Malaisrie, MD, Preeti Kansal, MD, and Patrick M. McCarthy, MD, Chicago, IllThe effect of early readmission for CHF is established in the medical, but not cardiac surgery,
patient population. A single-institution, retrospective study of cardiac surgery patients showed
readmission for CHF to independently predict worse survival. Targeted postoperative management
may be warranted in this patient group.)
Table of Contents (continued)CH
D
A
CD
PM
ET/B
S
TX620A The Journal of Thoracic an77 Comparing microvascular alterations during minimal extracorporeal
circulation and conventional cardiopulmonary bypass in coronary artery
bypass graft surgery: A prospective, randomized study(continued on page 22A
d Cardiovascular Surgery c September 2012Peter Donndorf, MD, Franziska K€uhn, MD, Brigitte Vollmar, MD, PhD, Jan R€osner, MD, PhD,
Andreas Liebold, MD, PhD, Philipp Gierer, MD, PhD, Gustav Steinhoff, MD, PhD, and Alexander
Kaminski, MD, PhD, Rostock and Ulm, GermanyMinimal extracorporeal circulation (MECC) systems have been associated with beneficial clinical
outcomes. The current study aimed at comparing microvascular alterations during conventional
extracorporeal circulation (CECC) andMECC during CABG. Analysis of the sublingual functional
capillary density suggests an advantageous recovery of the microvascular perfusion in MECC
compared with CECC.Evolving Technology/
Basic Science (ET/BS)
684 Dysregulated gene expression of extracellular matrix and adhesion molecules
in saphenous vein conduits of hemodialysis patients
Yongxin Sun, MD, Wenjun Ding, MD, Qiang Wei, MD, Zhenya Shen, MD, and
Chunsheng Wang, MD, Shanghai and Suzhou, ChinaThe present study disclosed that some extracellular matrix genes show significantly different
activity in the saphenous vein conduits of hemodialysis patients undergoing coronary artery bypass
grafting. The preoperative profile could provide useful clues regarding saphenous vein quality,
prompting adjustment in the surgical strategy.690 Endothelial preservation of the minimally manipulated saphenous vein
composite graft: Histologic and immunohistochemical study
Ho Young Hwang, MD, PhD, Min-A Kim, MD, PhD, Jeong Wook Seo, MD, PhD, and
Ki-Bong Kim, MD, PhD, Seoul, KoreaThree segments of saphenous vein were obtained from 20 patients. Histologic and
immunohistochemical studies revealed well-preserved endothelium in the saphenous vein
composite graft. Saphenous veins harvested with minimal surgical manipulation for use in
Y-composite grafts had better endothelial preservation.697 Endothelial nitric oxide synthase enhancer for protection of endothelial
function from asymmetric dimethylarginine–induced injury in human internal
thoracic artery
Chao Xuan, MPhil, Feng-Jun Chang, MD, Xiao-Cheng Liu, MD, Xiao-Yan Bai, MD,
Xiao-Long Liao, MD, Guo-Wei He, MD, PhD, DSc, and Jing-Song Ou, MD, PhD, FCCP, Tianjin
and Guangzhou, China; and Portland, OreEndothelial function may be damaged by asymmetric dimethylarginine. The endothelial nitric
oxide synthase enhancer AVE3085 reverses asymmetric dimethylarginine–induced endothelial
dysfunction in human internal thoracic artery by upregulation of endothelial nitric oxide synthase
expression and inhibition of superoxide anion production. This suggests potential endothelial
protection to improve long-term graft patency.)
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TX722A The Journal of Thoracic an04 Uniquely shaped cardiovascular stents enhance the pressure generation of
intravascular blood pumps(continued on page 23A
d Cardiovascular Surgery c September 2012Amy L. Throckmorton, PhD, James P. Carr, BS, William B.Moskowitz, MD, James J. Gangemi, MD,
Christopher M. Haggerty, BS, and Ajit P. Yoganathan, PhD, Richmond and Charlottesville, Va; and
Atlanta, GaThis study presents the evaluation of uniquely shaped filaments and diffuser blades in the
development of a protective stent for an intravascular cavopulmonary assist device for single
ventricle patients. The integration of these novel features onto protective stents could be broadly
applied to all intravascular blood pumps with the benefits of improving flow control, lowering the
operational rotational speed, reducing the risk of hemolysis and thrombosis, and enhancing energy
transfer.Cardiothoracic
Transplantation (TX)
710 Outcome of living-donor lobar lung transplantation using a single donor
Hiroshi Date, MD, Takeshi Shiraishi, MD, Seiichiro Sugimoto, MD, Tsuyoshi Shoji, MD,
Fengshi Chen, MD, Masafumi Hiratsuka, MD, Akihiro Aoyama, MD, Masaaki Sato, MD,
Masaomi Yamane, MD, Akinori Iwasaki, MD, Shinichiro Miyoshi, MD, Toru Bando, MD, and
Takahiro Oto, MD, Kyoto, Fukuoka, and Okayama, JapanWe retrospectively investigated 14 critically ill patients who had undergone living-donor lobar lung
transplantation using a single donor at 3 lung transplant centers in Japan. The 3- and 5-year survival
was 70% and 56%, respectively. Single living-donor lobar lung transplantation provides acceptable
results for sick patients who would die soon otherwise.716 Extracorporeal membrane oxygenation as a bridge to lung transplantation and
recovery
Jeffrey Javidfar, MD, Daniel Brodie, MD, Alex Iribarne, MD, MS, Julissa Jurado, MD,
Matthew LaVelle, MSE, Keith Brenner, MD, Selim Arcasoy, MD, Joshua Sonett, MD, and
Matthew Bacchetta, MD, New York, NYExtracorporeal membrane oxygenation is a safe and effective means of bridging well-selected
patients with refractory respiratory failure to lung transplantation or return to their baseline
condition.Surgical Techniques 722 Aortic valve repair by sinotubular junctional remodeling to eliminate aortic
regurgitation in donor cardiac allograft
David J. Kaczorowski, MD, and Y. Joseph Woo, MD, Philadelphia, Pa724 Surgical cryoablation for ventricular tachyarrhythmia in patients undergoing
surgical ventricular restoration: Lessons learned from radiofrequency ablation
Rao V. Parachuri, FRCS(Cth), and Srilakshmi M. Adhyapak, DNB, Bangalore, India726 Cardiopulmonary bypass strategy with low-dose heparin and nafamostat
mesilate in cardiac surgery: A safe option for patients with acute stroke
Naoto Morimoto, MD, PhD, Soichiro Henmi, MD, Masato Yoshida, MD, and Nobuhiko Mukohara,
MD, Himeji, Japan728 Transcatheter aortic valve implantation combined with conventional heart
surgery: Hybrid approach for complex cardiac pathologic features
Miralem Pasic, MD, PhD, Semih Buz, MD, Axel Unbehaun, MD, and Roland Hetzer, MD, PhD,
Berlin, Germany)
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The Journal of Thoracic and Cardiovascular Surgery c Volume 144, Number 3 23AZain Khalpey, MD, PhD, MRCS, Rene J. Dekkers, CCP, Foeke J. H. Nauta, MD, and
Prem Shekar, MD, Boston, Mass732 Percutaneous device closure of a pseudoaneurysm arising from the junction of
the innominate artery and the aortaD
A
CDawn C. Scantlebury, MBBS, Oluseun O. Alli, MBBS, Lyle D. Joyce, MD, and
Charanjit S. Rihal, MD, Rochester, MinnOnline Only:
Case Reports
e85 Combined surgical and ablative cure for localized sternal compression–induced
cardiomyopathy and ventricular tachyarrhythmia
Christopher V. DeSimone, MD, PhD, Sandeep Sagar, MD, Chris Moir, MD, and
Samuel J. Asirvatham, MD, Rochester, Minne87 Left main coronary artery atresia with tetralogy of Fallot: A novel association
Nikhil Prakash Patil, MS, MRCS, Smita Mishra, MD, DNB, Saket Agarwal, MCh, and DeepakPMKumar Satsangi, MCh, New Delhi, Indiae90 Simultaneous transapical transcatheter aortic and mitral valve replacement in
a high-risk patient with a previous mitral bioprosthesis
Adil H. Al Kindi, MD, Khaled F. Salhab, MD, Samir Kapadia, MD, Eric E. Roselli, MD,
Amar Krishnaswamy, MD, Andrew Grant, MD, Emin Murat Tuzcu, MD, and
Lars G. Svensson, MD, PhD, Cleveland, OhioeS92 Massive spontaneous hemorrhage in giant type 1 neurofibromatosis in soft
tissue of chest wall/B
ETKewei Zhang, MD, PhD, Jena Song, MS, Wenji Xiong, MD, PhD, Zhi Li, PhD,
Dianbo Cao, MD, PhD, Tianbo Jiang, HS, and Wei Liu, MD, PhD, Changchun,
China, and New York, NYe93 True aneurysm of anterior mitral leaflet—A rare entity
Trushar P. Gajjar, DNB, and Neelam B. Desai, MCh, DNB, Andhra Pradesh, Indiae95 Nonintubated thoracoscopic surgery for pulmonary lesions in both lungs
Tung-Ming Tsai, MD, and Jin-Shing Chen, MD, PhD, Taipei, TaiwaneT97 Acute ascending aortic dissection during transaortic balloon-expandable aortic
valve implantationX
Augusto D’Onofrio, MD, Chiara Tessari, MD, Roberto Bianco, MD, Giambattista Isabella, MD,
Guido Di Gregorio, MD, and Gino Gerosa, MD, Padova, ItalyLetters to the Editor 735 Patients with cancer and central pulmonary emboli treated surgically
Anna L. McGuire, MD, and Fraser Rubens, MD, MSc, Ottawa, Ontario, Canada735 Reply to the Editor
Marzia Leacche, MD, and John G. Byrne, MD, Nashville, Tenn)
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d Cardiovascular Surgery c September 2012Murat Tavlasoglu, MD, Diyarbakir, Turkey736 Reply to the Editor
Konstantinos Zannis, MD, and Laurens Mitchell-Heggs, MD, Paris, France738 The effect of innominate cannulation on cerebral perfusion
Sahin Bozok, MD, Mert Kestelli, MD, Hakan Karamustafa, MD, and Sedat Ozan Karakisi, MD,
Rize and _Izmir, Turkey738 Reply to the Editor
Enyi Shi, MD, PhD, and Tianxiang Gu, MD, PhD, Shenyang, China738 Alcohol and adhesions
Arkalgud Sampath Kumar, MCh, Ghaziabad, India739 Reply to the Editor
Antonio D. Lassaletta, MD, and Frank W. Sellke, MD, Providence, RI740 Atrioventricular valve competence and ventricular growth in biventricular
repair of unbalanced atrioventricular canal
Ali Dodge-Khatami, MD, PhD, Hamburg, Germany741 Reply to the Editor
John E. Foker, MD, PhD, Minneapolis, Minn742 Will local use of antibiotics be essential?
Hiroshi Osawa, MD, PhD, and Kouan Orii, MD, PhD, Chiba, Japan742 Reply to the Editor
Christoph Schimmer, MD, and Rainer Leyh, MD, PhD, W€urzburg, Germany743 Interleukin-6 and -10 as master predictive mediators of the
postcardiopulmonary bypass inflammatory response
Yves Denizot, PhD, and Nathalie Nathan, MD, PhD, Limoges, France743 Reply to the Editor
Jero^me Jouan, MD, Paris, France744 Invasive adenocarcinoma with bronchoalveolar features: A population-based
evaluation of the extent of resection in bronchoalveolar cell carcinoma
Sadeesh K. Srinathan, MD, MSc, Winnipeg, Manitoba, Canada744 Reply to the Editor
Shawn S. Groth, MD, MS, Bryan A. Whitson, MD, PhD, and Jonathan D’Cunha, MD, PhD,
Minneapolis, Minn)
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DThe American Board of Thoracic Surgery748 Notices
748 Requirements for Maintenance of CertificationReader Services 31A JTCVS Disclosure Statement32A Information for Readers PMSupplement S1 2011 Minimally Invasive Thoracic Surgery SummitIntroduction S2 Third International Biennial Minimally Invasive Thoracic Surgery Summit
Scott J. Swanson, MD, and Lawrence H. Cohn, MD, Boston, MassSession I: Lung Cancer
Diagnosis and Staging
S3 Lung cancer screening trials: The United States and beyond /B
SFrancine L. Jacobson, MD, MPH, and Michael T. Jaklitsch, MD, Boston, Mass
S7 Lung cancer screening trials: Denmark and beyond
Jesper H. Pedersen, MD, DMsci, Rene H. Petersen, MD, and Henrik J. Hansen, MD, Copenhagen,
Denmark
S9 Endobronchial ultrasonography (EBUS)—Its role in staging of non–small cell
lung cancer and who should do it?
Rafael S. Andrade, MD, David D. Odell, MD, MMSc, Jonathan D’Cunha, MD, PhD, and
Michael A. Maddaus, MD, Minneapolis, MinnEBUS is an accepted diagnostic modality to stage the mediastinum in patients with non–small
cell lung cancer. The reliability of EBUS is dictated by the probability of mediastinal
involvement, the clinical and technical expertise of the EBUS operator, and the experience of
the cytopathologist.S14 Is VAMLA/TEMLA the new standard of preresection staging of non–small cell
lung cancer?
Sai Yendamuri, MBBS, and Todd L. Demmy, MD, FACS, Buffalo, NYAccurate mediastinal staging of lung cancer is important for prognostication, treatment
optimization, and consistency of research data. The present report summarizes the existing data of
procedures used for transcervical mediastinal lymphadenectomy.
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TXS28A The Journal of Thoracic an18 The surgeon’s role in molecular biology(continued on page 29A
d Cardiovascular Surgery c September 2012Gaetano Rocco, MD, FRCSEd, FECTS, Naples, ItalyIn the pursuit of personalized medicine, thoracic surgeons will increasingly be called on to actively
participate in new diagnostic pathways aimed at clarifying biomolecular processes linked to lung
cancer development. Accordingly, keeping abreast of the research on biomolecular models is
rapidly becoming a professional imperative rather than an educational opportunity.Session II: Lung
Cancer Treatment
S23 Video-assisted thoracoscopic trisegmentectomy and left upper lobectomy
provide equivalent survivals for stage IA and IB lung cancer
Harmik J. Soukiasian, MD, Edward Hong, MD, and Robert J. McKenna, Jr, MD, Los Angeles, CalifResection of the upper division and complete left upper lobectomy were compared. The hospital
course, morbidity, mortality, and survival were the same so the lingula does not need to be resected
for stage 1A and 1B tumors if resection of the upper division provides good margins.S27 One-port (uniportal) video-assisted thoracic surgical resections—A clear
advance
Gaetano Rocco, MD, FRCSEd, FETCS, Naples, ItalyUniportal wedge VATS resections of peripheral nodules can help in solving diagnostic dilemmas,
be of therapeutic benefit, and provide tissue for biomolecular studies.S32 Video-assisted thoracoscopic mediastinal lymph node dissection
Onkar V. Khullar, MD, and Sidhu P. Gangadharan, MD, Boston, MassSession III: Lung
Cancer—Other
Considerations
S35 American College of Surgeons Oncology Group Z4099/Radiation Therapy
Oncology Group 1021: A randomized study of sublobar resection compared
with stereotactic body radiotherapy for high-risk stage I non–small cell lung
cancer
Hiran C. Fernando, MD, and Robert Timmerman, MD, Boston, Mass, and Dallas, TexAn overview of a multicenter randomized study comparing sublobar resection and stereotactic
body radiotherapy for lung cancer is provided.S39 Adjuvant chemotherapy for surgically resected non–small cell lung cancer
Stephanie Heon, MD, and Bruce E. Johnson, MD, Boston, MassThis review summarizes the evidence underlying adjuvant chemotherapy in NSCLC. Based on
several randomized trials and 2 meta-analyses, adjuvant cisplatin-based chemotherapy is
considered the standard of care for patients with resected stage II-IIIA NSCLC. The benefit for
patients with resected stage IB NSCLC is less concrete.Session IV: Training/
Education/Technology
S43 Simulation for technical skills
M. Blair Marshall, MD, Washington, DCThe use of simulation will be necessary for most residents to develop adequate advanced technical
skills in our current training environment. The development and validation of simulation models is
necessary to meet the increasing need of a technical skills curriculum for thoracic surgery
education.)
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DS48 Use of energy-based coagulative fusion technology and lung sealants during
anatomic lung resection(continued on page 30A
The Journal of Thoracic and Cardiovascular Surgery c Volume 144, Number 3 29AMatthew J. Schuchert, MD, Ghulam Abbas, MD, Joshua P. Landreneau, BS,
James D. Luketich, MD, and Rodney J. Landreneau, MD, Pittsburgh, PaDEnergy-based tissue fusion technology can be applied safely in the division of the pulmonary
vasculature during anatomic lung resection. The use of surgical sealants and buttressing adjuncts
might reduce the incidence of perioperative air leaks.CS52 Thoracoscopic maneuvers for chest wall resection and reconstruction ATodd L. Demmy, MD, Sai Yendamuri, MBBS, Mark W. Hennon, MD, Elisabeth U. Dexter, MD,
Anthony L. Picone, MD, PhD, and Chukwumere Nwogu, MD, Buffalo, NYThoracoscopic chest wall resection is an advanced technique for which the indications are limited.
This report aims to consolidate and categorize the technical maneuvers used by one center and
reported by others to ease its adoption by experienced surgeons who wish to apply it in selected
circumstances.S58 Tracheobronchoplasty for the treatment of tracheobronchomalacia MPKiran H. Lagisetty, MD, and Sidhu P. Gangadharan, MD, Boston, MassSession VI: Malignant
Esophagus
S60 Minimally invasive Ivor Lewis esophagectomy
Jon O. Wee, MD, and Christopher R. Morse, MD, Boston, MassS63 Three-field minimally invasive esophagectomy: Current results and technique
Yaron Perry, MD, and Hiran C. Fernando, MD, Savannah, Ga, and Boston, MassB
SET
/Surgical removal of the esophagus continues to play a major role in the treatment of esophageal
cancer. However, esophagectomy is a complex procedure, associated with significant morbidity and
mortality. Several series have shown low perioperative mortality with minimally invasive
esophagectomy. A major advantage compared with esophagectomy with thoracotomy is a lower
incidence of respiratory complications, a significant predictor of mortality in many studies. We
review the technique and results of 3-hole minimally invasive esophagectomy. We favor
thoracoscopic esophageal mobilization with the patient in a lateral decubitus position; however, we
continue to use the 3-hole approach for those patients with midesophageal cancers, patients with
long-segment Barrett’s esophagus extending to the midthoracic esophagus, and for patients with
long-segment benign disorders such as end-stage achalasia or complex benign strictures.X
Session VII:
Esophagus—Benign
S67 Giant paraesophageal hernia repair: Technical pearls
TMara B. Antonoff, MD, Jonathan D’Cunha, MD, PhD, Rafael S. Andrade, MD, and
Michael A. Maddaus, MD, Minneapolis, MinnThe optimal operative management for giant paraesophageal hiatal hernias continues to evolve,
with recent series reporting promising results with minimally invasive approaches. Our technical
approach to this procedure involves a consistent emphasis on several key operative points:
Circumferential sac dissection with maintenance of crural integrity, extensive mediastinal
esophageal dissection, crural closure with pledgeted sutures, wedge Collis gastroplasty for
shortened esophagus, 3-stitch fundoplication incorporating esophageal tissue with each bite,
additional sutures securing the top of the fundoplication to the crura, and biologic mesh buttressing.
We believe that, with diligence paid toward these key steps, laparoscopic giant paraesophageal
hiatal hernia repair can be performed with similar outcomes as the open approach while avoiding
the morbidity of a thoracotomy or laparotomy.)
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functional results.S74 Endoscopic management of gastroesophageal reflux disease: A review
Chaitan K. Narsule, MD, Jon O. Wee, MD, and Hiran C. Fernando, MD, FRCS, Boston, MassEndoscopic approaches for the treatment of GERD have been the focus of intense efforts during the
past decade. The present report describes the history of endoscopic therapies for GERD and reviews
the current data for endoscopic fundoplication.Session VIII: Innovation
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S80 Developing intrathoracic sentinel lymph node mapping with near-infrared
fluorescent imaging in non–small cell lung cancer
Denis M. Gilmore, MD, Onkar V. Khullar, MD, and Yolonda L. Colson, MD, PhD, Boston, MassWith poor survival and high recurrence rates, early-stage lung cancer currently appears to be
understaged or undertreated, or both. Although sentinel lymph node biopsy is standard for patients with
breast cancer and melanoma, its success has been unreliable in NSCLC. Sentinel lymph node biopsy
might aid in the identification of lymph nodes at the greatest risk of metastasis and allow for more
detailed analysis to select for patients whomight benefit from adjuvant therapy. The early results in our
recent clinical trial of patients with early-stage lung cancer have suggested that near-infrared imaging
might offer a platform for reliable sentinel lymph node identification in these patients.Earn CME credits at http://cme.ctsnetjournals.org
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